multivessel

ESC 2023

ESC 2023 | FIRE-Trial: Physiology Guided Complete Revascularization Benefits Elderly Patients with Myocardial Infarction

Patients over 75 with acute coronary syndrome (ACS) are often badly represented in most significant studies.&nbsp; In this context, the FIRE study looked to determine whether physiology guided complete revascularization is superior to culprit-only revascularization in elderly patients with multivessel disease suffering acute MI.&nbsp; The study included SCA patients over 75, hospitalized for both STEMI<a href="https://solaci.org/en/2023/08/29/esc-2023-fire-trial-physiology-guided-complete-revascularization-benefits-elderly-patients-with-myocardial-infarction/" title="Read more" >...</a>

stent-liberador-drogas-sirolimus-everolimus

EASTBOURNE Registry: Use of Sirolimus-Coated Balloons in Coronary Artery Disease

The introduction of drug coated balloons (DCB) has become an innovative therapeutic alternative to current treatments. Paclitaxel-coated balloons (PCB) have been used to treat in-stent restenosis (ISR) and also approach CAD in native arteries. More recently, sirolimus-coated balloons (SCB) are being looked at as part of pilot studies and smaller registries with preliminary results.&nbsp; The<a href="https://solaci.org/en/2023/08/23/eastbourne-registry-use-of-sirolimus-coated-balloons-in-coronary-artery-disease/" title="Read more" >...</a>

13th ProEducar-SOLACI Fellows Course Held at SOLACI-SBHCI 2023

ProEducar-SOLACI Fellows Course continues to grow! For the thirteenth consecutive year, the traditional SOLACI course for fellow interventionists was held at SOLACI-SBHCI 2023. The course led by Dr. Leandro Lasave (ARG) and codirected by Drs. Gabriel Maluenda (CHL), Breno Falcão (BRA) and Ricardo Costa (BRA), took place on August 2 at the URCA room of<a href="https://solaci.org/en/2023/08/04/13th-proeducar-solaci-fellows-course-held-at-solaci-sbhci-2023/" title="Read more" >...</a>

Relación entre calidad del vaso distal y resultados en tratamiento percutáneo de las oclusiones totales crónicas

EuroCTO: Safety and Benefit at 3 Years

Chronic total occlusions (CTOs) account for approximately 15-20% of patients with stable coronary artery disease. This field has seen various advances regarding treatment, leading to an improvement in the success rate of procedures. According to registries and randomized studies, the main indication for percutaneous coronary intervention (PCI) of CTO should be based more on clinical<a href="https://solaci.org/en/2023/07/24/eurocto-safety-and-benefit-at-3-years/" title="Read more" >...</a>

ProEducar-SOLACI Fellows Course 2023 &#8211; Participate for a grant for the SCAI Fellows Course

For the thirteenth consecutive year, we will be hosting an educational excellence course for interventionalists in training from Latin America: the&nbsp;ProEducar-SOLACI Fellows Course. This one-day intensive course covers the most important topics in interventional cardiology with a practical focus. 5 Thematic Modules At the end of the course, there will be a optional final exam.<a href="https://solaci.org/en/2023/07/20/proeducar-solaci-fellows-course-2023-participate-for-a-grant-for-the-scai-fellows-course/" title="Read more" >...</a>

Claves para mejorar la productividad en la sala de cateterismo

Useful Predictor of Adverse Events in Complex PCI: BCIS CHIP Score

Among patients undergoing percutaneous coronary intervention (PCI), there is a need for risk stratification for successful planning and post procedural management. Risk stratification is paramount for effective decision making.&nbsp; For a long time, the SYNTAX score has been the preferred tool for complex PCI patient risk assessment. However, it has important limitations, such as inter-observer<a href="https://solaci.org/en/2023/06/02/useful-predictor-of-adverse-events-in-complex-pci-bcis-chip-score/" title="Read more" >...</a>

The most read scientific articles in interventional cardiology in March on our website

Below, we share March&#8217;s most read scientific abstracts in interventional cardiology at solaci.org. ACC 2023 | YELLOW III Study. Effect of Evolocumab on Coronary Plaque Characteristics in Stable Coronary Artery Disease Dr. Kini presented the results of the YELLOW III Study where she analyzed the effect of evolocumab on coronary plaque in patients with stable<a href="https://solaci.org/en/2023/04/13/the-most-read-scientific-articles-in-interventional-cardiology-in-march-on-our-website/" title="Read more" >...</a>

The most read scientific articles in interventional cardiology in February on our website

Below, we share February&#8217;s most read scientific abstracts in interventional cardiology at solaci.org. Can Drug Coated Balloon Be a Valid Option for Small Vessels? One of the challenges of percutaneous coronary interventions (PCI) are &lt;2.5 mm vessels, since complications and restenosis complications rate are higher than with &gt;3.0 mm vessels.&nbsp;&nbsp; Is Using Drug-Eluting Balloons and<a href="https://solaci.org/en/2023/03/22/the-most-read-scientific-articles-in-interventional-cardiology-in-february-on-our-website/" title="Read more" >...</a>

ACC 2023 | PULSE-AF

Catheter ablation is an effective treatment for patients with atrial fibrillation (AF) refractory to the standard medical treatment. Verma et al. conducted a global, prospective, multicenter, nonrandomized study in which patients were operated with the PulseSelect system—pulmonary vein isolation using a nonthermal ablation system—and followed-up at 12 months. The system consists in nonthermal ablation, discharging<a href="https://solaci.org/en/2023/03/10/acc-2023-pulse-af-3/" title="Read more" >...</a>

ACC 2023 | RENOVATE-COMPLEX-PCI: Intravascular Imaging-Guided vs. Angiography-Guided Complex PCI

Patients with complex coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) have worse clinical outcomes tan patients with non-complex CAD. Several studies have shown that the use of intravascular imaging (IVUS, OCT) have reduced major adverse events vs. angiography guided PCI. However, these studies present limitations both of size, studied population, short term followup<a href="https://solaci.org/en/2023/03/08/acc-2023-renovate-complex-pci-intravascular-imaging-guided-vs-angiography-guided-complex-pci/" title="Read more" >...</a>

Top